Stockscreener 앱 받기
12.52
27.49%
2.70
시장 영업 전:
12.85
0.33
+2.64%
전일 마감가:
$9.82
열려 있는:
$9.98
하루 거래량:
122.24K
Relative Volume:
5.42
시가총액:
$335.01M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-10.19%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$9.60
$13.82
1주일 범위
$9.60
$13.89
52주 변동 폭
$9.60
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
Compare CNXU vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
12.52 | 262.77M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Conexeu Sciences Inc 주식(CNXU)의 최신 뉴스
Conexeu builds board as regenerative tissue ambitions widen - The Pharma Letter
Conexeu Sciences Inc. 2026 Q2 10-Q Report: Financials, Risks, and Company Overview - Minichart
Conexeu Sciences Inc. 3Q 2026: Revenue $0 Net loss $2.3M, EPS $(0.11) — 10-Q Summary - TradingView
CNXU: Board expanded to nine, with updated director compensation and new CCO agreement featuring equity awards - TradingView
Conexeu Sciences expands board, names chief commercial officer By Investing.com - Investing.com South Africa
Conexeu Sciences expands board, names chief commercial officer - Investing.com
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing - The Manila Times
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Conexeu Sciences Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Conexeu Sciences Inc. Rings the Closing Bell - Nasdaq
MC_061026_tower-shot.jpg - Nasdaq
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus - GlobeNewswire
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program - The National Law Review
Conexeu Sciences Inc. Reports Manufacturing Scale Up And Regulatory Progress For Lead CXU Wound Care Program - marketscreener.com
Conexeu Sciences stock gains on wound care device progress By Investing.com - Investing.com South Africa
Conexeu Sciences stock gains on wound care device progress - Investing.com
Conexeu Sciences provides update on manufacturing scale up for wound care device - TipRanks
Conexeu advances manufacturing for wound care device ahead of 2027 FDA filing - Investing.com
Flowable gel for complex wounds readied for 2027 FDA 510(k) bid - Stock Titan
The Body as Blueprint - lifehealth.com
Top SkyAI, Inc. Warrant (SKYAW) Competitors 2026 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
2026 Special Olympics USA Games Rings the Nasdaq Stock Market Closing Bell - Nasdaq
CNXU Technical Analysis | Trend, Signals & Chart Patterns | CONEXEU SCIENCES INC (NASDAQ:CNXU) - ChartMill
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early - Investing.com
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early - sharewise.com
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 - The Manila Times
Top Inspira Technologies OXY B.H.N. (QTEX) Competitors 2026 - MarketBeat
Conexeu Sciences (CNXU) Stock Price, News & Analysis - MarketBeat
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts - marketscreener.com
How Investors Are Reacting To Conexeu Sciences (CNXU) 3D-Printed Bioregenerative Breast Matrix Initiative - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch - RTTNews
Assessing Conexeu Sciences (CNXU) Valuation After Launch Of Preclinical B.R.E.A.S.T. Program - simplywall.st
CNXU Price History for Conexeu Sciences Stock - Barchart.com
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat
Conexeu Sciences Inc. (CNXU) Competitors - Meyka
Conexeu Debuts on Nasdaq With Preclinical Regenerative Tissue Platform - 3D Printing Industry
Regenerative Breast Matrix Platforms - Trend Hunter
Conexeu Sciences (CNXU) Stock Chart and Price History 2026 - MarketBeat
Conexeu Sciences launches preclinical program for bioregenerative breast matrix - BioWorld News
CNXU Stock Chart | CONEXEU SCIENCES INC (NASDAQ:CNXU) - ChartMill
Conexeu Sciences Inc (CNXU) 재무 분석
Conexeu Sciences Inc (CNXU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Conexeu Sciences Inc 주식 (CNXU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sharpe Jeffrey Nathan | Director |
May 22 '26 |
Option Exercise |
0.00 |
500,000 |
500 |
1,000,000 |
1.27%
1.43%
자본화:
|
볼륨(24시간):